Developing therapeutic drugs for pancreatic cancer and hepatitis B and C.
Industry: Health Care
First Day Return: +10.5%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 03/17/2014 |
Offer Price | $10.00 |
Price Range $15.00 - $15.00 | |
Offer Shares (mm) | 1.5 |
Deal Size ($mm) | $15 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/01/2014 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $15 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Louisville, CO, United States |
Founded | 1995 |
Employees at IPO | 25 |
Website www.globeimmune.com |